SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-040248
Filing Date
2024-05-07
Accepted
2024-05-07 08:05:16
Documents
3
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0205373-6k_haoxi.htm 6-K 13234
2 BIDDING DATA PROMOTION REBATE AGREEMENT, DATED APRIL 29, 2024, BY AND BETWEEN BE ea020537301ex10-1_haoxi.htm EX-10.1 228024
3 PRESS RELEASE - HAOXI HEALTH TECHNOLOGY LIMITED ENTERS INTO REBATE AGREEMENT WIT ea020537301ex99-1_haoxi.htm EX-99.1 9662
  Complete submission text file 0001213900-24-040248.txt   252061
Mailing Address 801/802, TOWER C, BUILDING 103 HUIZHONGLI, CHAOYANG DISTRICT BEIJING F4 100101
Business Address 801/802, TOWER C, BUILDING 103 HUIZHONGLI, CHAOYANG DISTRICT BEIJING F4 100101 86-10-13311587976
Haoxi Health Technology Ltd (Filer) CIK: 0001954594 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-41933 | Film No.: 24919712
SIC: 7311 Services-Advertising Agencies
(CF Office: 07 Trade & Services)